Opiant Pharmaceuticals is a biotechnology company founded in 2009 in the United States. The company focuses on creating best-in-class medicines for the treatment of addictions and drug overdose. Their recent milestone involved a partnership with Indivior, which has acquired Opiant Pharmaceuticals. As a result, the Opiant Pharmaceuticals page is no longer active, and all updates and content will be channeled through Indivior's platform. While the details of the acquisition and the specific terms of the deal are not disclosed, this strategic move aligns with both companies' vision to tackle addiction and substance abuse through innovative pharmaceutical solutions.
Opiant Pharmaceuticals
Founded 2009
Santa Monica, United States
6 employees
Grant
Biotechnology, Health Care +2
Santa Monica, United States
6 employees
Grant
Biotechnology, Health Care +2
General Information
Company Name
Opiant Pharmaceuticals
Founded Year
2009
Location
Santa Monica, United States
Santa Monica, United States
Employees
6
Industries
Biotechnology, Health Care, Health and Wellness +1
Funding Stage
Grant
Social
BounceWatch is an independent company data service, not affiliated with Opiant Pharmaceuticals. To contact Opiant Pharmaceuticals, visit opiant.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Opiant Pharmaceuticals compare?
A PDF of Opiant Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Opiant Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Opiant Pharmaceuticals on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Opiant Pharmaceuticals
No funding data available for Opiant Pharmaceuticals yet.
Opiant Pharmaceuticals Alternatives & Competitors
View All Alternatives
Opiant Pharmaceuticals vs
Global Blood Therapeutics
United States
Global Blood Therapeutics (GBT) is now part of Pfizer, and we look forward to continuing our mission...
Post-IPO Debt
100 employees
Biotechnology, Health and Wellness
Opiant Pharmaceuticals vs
Opiant Pharmaceuticals vs
89bio
United States
Developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic...
Post-IPO Equity
123 employees
Biopharma, Biotechnology
FAQ About Opiant Pharmaceuticals
Opiant Pharmaceuticals, Inc. is now part of Indivior, and we look forward to continuing our mission to create best-in-class medicines for the treatment of addictions and drug overdose. The Opiant Pharmaceuticals page will no longer be active or monitored. Please follow Indivior for new content.
Opiant Pharmaceuticals was founded in 2009.
Opiant Pharmaceuticals is headquartered in Santa Monica, United States.
Opiant Pharmaceuticals operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical.
Opiant Pharmaceuticals has approximately 6 employees.
Top alternatives and competitors to Opiant Pharmaceuticals include Global Blood Therapeutics, Metsera, 89bio, Interius BioTherapeutics, Arcellx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Opiant Pharmaceuticals and Global Blood Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Opiant Pharmaceuticals, https://bouncewatch.com/company/opiant-pharmaceuticals, updated 7 January 2025. When citing, please name BounceWatch and link this page.
